Aytu BioPharma

Youtube Subscribe

Open: 2.6 Close: 2.38 Change: -0.22

What an AI can tell you about Aytu BioPharma before investing.

Are looking for the most relevant information about Aytu BioPharma? Investor spend a lot of time searching for information to make investment decisions in Aytu BioPharma. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Aytu BioPharma are: Aytu, BioPharma, stock, AYTU, split, Inc, Announces, and the most common words in the summary are: aytu, stock, biopharma, inc, price, company, bioscience, . One of the sentences in the summary was: Aytu biopharma Inc (AYTU) received a consensus rating of Buy.. Other …

Concept Map

Semantic Network

Stock Summary

Aytu Biopharma, Inc. focuses on developing and commercializing novel therapeutics and consumer healthcare products. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in.

Today's Summary

Aytu Biopharmas stock price per share is $2.43 today (as of Apr 26, 2023) Aytu BioPharma stock is down -3.37% while the S&P 500 has gained 1.19%. Aytu biopharma Inc (AYTU) received a consensus rating of Buy.

Today's News

Aytu BioPharma Inc. Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer. Company Expects to improve ADHD Product Margins by an Estimated 15%. Company expects to realize an estimated 15%. Aytu Biopharmas stock price per share is $2.43 today (as of Apr 26, 2023) Aytu BioPharma stock is down -3.37% while the S&P 500 has gained 1.19% as of 11:59 AM on Thursday, Apr 27. Aytu biopharma Inc (AYTU) received a consensus rating of Buy. Aytu BioPharma Announces Closing of $7.30. How many reverse splits has AYTU BioPharmarma (AYTU) has 2 splits in our AYTs stock split history database. Aytu Biopharmaceutical company focused on commercializing novel products.

Stock Profile

"Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from six years and older; and Cotempla XR-ODT for the treatment of ADHD in patients from six to seventeen years old. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; and Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado."

Keywords

How much time have you spent trying to decide whether investing in Aytu BioPharma? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Aytu BioPharma are: Aytu, BioPharma, stock, AYTU, split, Inc, Announces, and the most common words in the summary are: aytu, stock, biopharma, inc, price, company, bioscience, . One of the sentences in the summary was: Aytu biopharma Inc (AYTU) received a consensus rating of Buy.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #aytu #stock #biopharma #inc #price #company #bioscience.

Read more →

Youtube Subscribe

---